In glioma tissues and cells, miR-383 downregulation causes the upregulation of CIP2A, which was linked with larger tumor size, higher grade, and shorter survival time in patients (Zhang and Wang, 2020). The gene discussed is CIP2A; the disease is central nervous system cancer.